On May 3, 2021 ChromaDex Corp. (NASDAQ: CDXC) reported that is scheduled to participate in a virtual presentation at the Benzinga Small Cap Conference on Thursday, May 13, 2021 at 11:30am ET (8:30am PT) (Press release, ChromaDex, MAY 3, 2021, View Source [SID1234579009]). ChromaDex CEO, Rob Fried, will also be presenting on a panel in the Transformative Healthcare track, entitled "Investing in Longevity Science: The New Drugs & Therapies Designed to Prolong Your Lifespan." The panel is scheduled for Thursday, May 13, 2021 at 1:20pm ET.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The Global Small Cap Conference is a day dedicated to bridging the gap between Small Cap companies, investors and traders. The event will have multiple days of networking and education in a virtual setting.

A webcast of the company presentation will be posted under the investor relations section of ChromaDex’s website at www.chromadex.com, or can be accessed at View Source A replay of the presentation will be available following the event.

To learn more about small-cap innovation and investing at the Benzinga Global Small Cap Conference, click here.